Denkert C - Search Results

1

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.

Györffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, Szallasi Z. Györffy B, et al. Among authors: denkert c. Breast Cancer Res Treat. 2010 Oct;123(3):725-31. doi: 10.1007/s10549-009-0674-9. Epub 2009 Dec 18. Breast Cancer Res Treat. 2010. PMID: 20020197

2

Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.

Denkert C, Winzer KJ, Müller BM, Weichert W, Pest S, Köbel M, Kristiansen G, Reles A, Siegert A, Guski H, Hauptmann S. Denkert C, et al. Cancer. 2003 Jun 15;97(12):2978-87. doi: 10.1002/cncr.11437. Cancer. 2003. PMID: 12784332

3

Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression.

Denkert C, Weichert W, Pest S, Koch I, Licht D, Köbel M, Reles A, Sehouli J, Dietel M, Hauptmann S. Denkert C, et al. Cancer Res. 2004 Jan 1;64(1):189-95. doi: 10.1158/0008-5472.can-03-1987. Cancer Res. 2004. PMID: 14729623

4

Prognostic impact of cyclooxygenase-2 in breast cancer.

Denkert C, Winzer KJ, Hauptmann S. Denkert C, et al. Clin Breast Cancer. 2004 Feb;4(6):428-33. doi: 10.3816/cbc.2004.n.006. Clin Breast Cancer. 2004. PMID: 15023244 Review.

5

Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance.

Surowiak P, Materna V, Matkowski R, Szczuraszek K, Kornafel J, Wojnar A, Pudelko M, Dietel M, Denkert C, Zabel M, Lage H. Surowiak P, et al. Among authors: denkert c. Breast Cancer Res. 2005;7(5):R862-70. doi: 10.1186/bcr1313. Epub 2005 Aug 25. Breast Cancer Res. 2005. PMID: 16168133 Free PMC article.

6

Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations.

Györffy B, Surowiak P, Kiesslich O, Denkert C, Schäfer R, Dietel M, Lage H. Györffy B, et al. Among authors: denkert c. Int J Cancer. 2006 Apr 1;118(7):1699-712. doi: 10.1002/ijc.21570. Int J Cancer. 2006. PMID: 16217747

7

Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status.

Fritzsche F, Gansukh T, Borgoño CA, Burkhardt M, Pahl S, Mayordomo E, Winzer KJ, Weichert W, Denkert C, Jung K, Stephan C, Dietel M, Diamandis EP, Dahl E, Kristiansen G. Fritzsche F, et al. Among authors: denkert c. Br J Cancer. 2006 Feb 27;94(4):540-7. doi: 10.1038/sj.bjc.6602956. Br J Cancer. 2006. PMID: 16434994 Free PMC article.

8

Prognostic relevance of AGR2 expression in breast cancer.

Fritzsche FR, Dahl E, Pahl S, Burkhardt M, Luo J, Mayordomo E, Gansukh T, Dankof A, Knuechel R, Denkert C, Winzer KJ, Dietel M, Kristiansen G. Fritzsche FR, et al. Among authors: denkert c. Clin Cancer Res. 2006 Mar 15;12(6):1728-34. doi: 10.1158/1078-0432.CCR-05-2057. Clin Cancer Res. 2006. PMID: 16551856

9

Expression patterns of polo-like kinase 1 in human gastric cancer.

Weichert W, Ullrich A, Schmidt M, Gekeler V, Noske A, Niesporek S, Buckendahl AC, Dietel M, Denkert C. Weichert W, et al. Among authors: denkert c. Cancer Sci. 2006 Apr;97(4):271-6. doi: 10.1111/j.1349-7006.2006.00170.x. Cancer Sci. 2006. PMID: 16630118

10

Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis.

Weichert W, Röske A, Gekeler V, Beckers T, Ebert MP, Pross M, Dietel M, Denkert C, Röcken C. Weichert W, et al. Among authors: denkert c. Lancet Oncol. 2008 Feb;9(2):139-48. doi: 10.1016/S1470-2045(08)70004-4. Lancet Oncol. 2008. PMID: 18207460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results